875548-62-2

Upstream product

• 875446-35-8 (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-iodo-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one 
• 73183-34-3 bis(pinacol)diborane 
• 163444-17-5 2-iodo-4-(trifluoromethyl)aniline 
• 6526-08-5 2-amino-5-(trifluoromethyl)benzonitrile 
• 875444-08-9 (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one 
• 868166-20-5 2-iodo-5-(trifluoromethyl)benzonitrile 
• 702641-05-2 [2-iodo-5-(trifluoromethyl)phenyl]methanol 
• 702641-06-3 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene 
• 702641-04-1 2-iodo-5-(trifluoromethyl)benzoic acid 
• 871917-79-2 benzyl {(1S)-2-[3,5-bis(trifluoromethyl)phenyl]-1-methyl-2-oxoethyl}carbamate 

Relevant academic research and scientific papers

CETP INHIBITORS

Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.